PANCREATIC CANCER METASTATIC
Clinical trials for PANCREATIC CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer patients with painful fluid buildup
Disease control Not yet recruitingThis study tests whether putting an immunotherapy drug called adebrelimab directly into the fluid-filled space in the belly or chest can help control the fluid and improve outcomes in people with advanced pancreatic cancer. About 20 participants will receive the drug plus standar…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sizhen Wang • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
New vaccine combo targets tough pancreatic cancer
Disease control Not yet recruitingThis early-phase trial tests a new tumor vaccine (SapDM275) combined with standard chemotherapy (AG regimen) in 13 people with metastatic pancreatic cancer who have not had prior treatment. The goal is to see if the combination is safe and can help control the disease. Participan…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: EARLY_PHASE1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for tough pancreatic cancer: combo therapy targets tumors after first treatment fails
Disease control Not yet recruitingThis study tests a new drug called IBI363 combined with chemotherapy for people with advanced pancreatic cancer that has worsened after initial treatment. About 48 participants will receive the combination until their disease progresses or side effects become too severe. The goal…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Personalized T-Cell therapy takes on pancreatic cancer
Disease control Not yet recruitingThis early-phase trial tests a new treatment called MT-601 for people with advanced pancreatic cancer that cannot be removed by surgery or has spread. MT-601 uses a patient's own immune cells, specially trained to attack multiple cancer targets, given alongside chemotherapy. The …
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1 • Sponsor: Marker Therapeutics, Inc. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Can a lab test outsmart pancreatic cancer? new study aims to find out
Knowledge-focused Not yet recruitingThis study looks at whether a new type of lab test can predict which chemotherapy will work best for people with metastatic pancreatic cancer. Researchers will compare the test's predictions to what actually happens in patients receiving standard treatments. The study does not pr…
Matched conditions: PANCREATIC CANCER METASTATIC
Sponsor: Prof. Dr. med. Dres. h.c. Jan Schmidt, MME • Aim: Knowledge-focused
Last updated May 26, 2026 05:02 UTC